Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Gerald Marit"'
Autor:
Gerald Marit, Jean-Baptiste Pinaquy, Charles Mesguich, Baudouin Denis de Senneville, Elif Hindié, Ghoufrane Tlili, Olivier Saut
Publikováno v:
Nuclear Medicine Communications
Nuclear Medicine Communications, 2021, 42 (10), pp.1135-1143. ⟨10.1097/MNM.0000000000001437⟩
Nuclear Medicine Communications, Lippincott, Williams & Wilkins, 2021, 42 (10), pp.1135-1143. ⟨10.1097/MNM.0000000000001437⟩
Nuclear Medicine Communications, 2021, 42 (10), pp.1135-1143. ⟨10.1097/MNM.0000000000001437⟩
Nuclear Medicine Communications, Lippincott, Williams & Wilkins, 2021, 42 (10), pp.1135-1143. ⟨10.1097/MNM.0000000000001437⟩
Objectives In multiple myeloma, the diagnosis of diffuse bone marrow infiltration on 18-FDG PET/CT can be challenging. We aimed to develop a PET/CT radiomics-based model that could improve the diagnosis of multiple myeloma diffuse disease on 18-FDG P
Autor:
Axelle Lascaux, Gerald Marit, Valerie Latrabe, Laurence Bordenave, Charles Mesguich, Cyrille Hulin, Elif Hindié
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1938, p 1938 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1938, p 1938 (2021)
Volume 13
Issue 8
To compare the prognostic values of 18-FDG PET/CT (FDG-PET) and Whole-Body MRI with Diffusion-Weighted Imaging (WB-DW-MRI) in the evaluation of treatment response of Multiple Myeloma (MM) patients eligible for ASCT. Thirty patients with newly diagnos
Autor:
Charles Mesguich, Gerald Marit, Valerie Latrabe, Laurence Bordenave, Elif Hindié, Paul Perez, Julien Asselineau, Cyrille Hulin
Publikováno v:
JMIR Research Protocols, Vol 9, Iss 9, p e17850 (2020)
JMIR Research Protocols
JMIR Research Protocols
Background The International Myeloma Working Group recommends the use of 18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for treatment response evaluation, as it is superior to magnetic resonance imaging (MRI). H
Autor:
Cyrille Hulin, Valerie Latrabe, Charles Mesguich, Axelle Lascaux, Gerald Marit, Elif Hindié, Laurence Bordenave
Publikováno v:
Annals of hematology. 99(12)
Magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18FDG 18F-FDG PET-CT) are standard procedures for staging multiple myeloma (MM). Diffusion-weighted sequences applied to whole-body MRI (WB-
Autor:
Paul G. Richardson, Hervé Avet-Loiseau, Benoit Dupas, Martine Escoffre-Barbe, Aurore Perrot, Eric Frampas, Caroline Bodet-Milin, Lotfi Benboubker, Michel Attal, Thierry Facon, Gerald Marit, Jean-Richard Eveillard, Florence Caillon, Cyrille Hulin, Véronique Dorvaux, Lionel Karlin, Carine Chaleteix, Denis Caillot, Anne-Marie Stoppa, Brigitte Pegourie, Philippe Moreau, Kamel Laribi, Laurent Garderet, Jean-Michel Nguyen, Nikhil C. Munshi, Kenneth C. Anderson, Aurélie Gaultier, Margaret Macro, Françoise Kraeber-Bodéré
Publikováno v:
Journal of Clinical Oncology. 35:2911-2918
Purpose Magnetic resonance imaging (MRI) and positron emission tomography–computed tomography (PET-CT) are important imaging techniques in multiple myeloma (MM). We conducted a prospective trial in patients with MM aimed at comparing MRI and PET-CT
Autor:
Bertrand Joly, Hagay Sobol, Isabelle Azais, Hervé Avet-Loiseau, Karine Augeul-Meunier, Catherine Le Bris, Delphine Demangel, Maroulio Pertesi, Xavier Leleu, Maria Victoria Revuelta, Maxime Vallée, Manuel Cliquennois, James D. McKay, Aurore Perrot, Aleksandra Butrym, Matthieu Foll, Björn Nilsson, Javier Oliver, Judit Várkonyi, Emeline Perrial, Xiaomu Wei, Artur Jurczyszyn, Gabriele Buda, Marcin Rymko, Cécile Leyronnas, Robert J. Klein, Elżbieta Iskierka-Jażdżewska, Claire Mathiot, Marzena Wątek, Eric Voog, Olivier Decaux, Florence Desquesnes, Jill Corre, Arnon Nagler, Jean Gabriel Fuzibet, Véronique Dorvaux, Jan Maciej Zaucha, Philippe Rodon, Siwei Chen, Denis Caillot, Laurent Garderet, Michel Maigre, Isabelle Leduc, Fabienne Lesueur, Borhane Slama, Sophie Rigaudeau, Philippe Mineur, Norbert Grząśko, Perrine Galia, Rui Manuel Reis, Federico Canzian, Philippe Helias, Yves-Jean Bignon, Marcin Kruszewski, Victor Moreno, Juan Sainz, Nathalie Cheron, Laurent Voillat, Charles Dumontet, Christian Berthou, Marie Beaumont, Brigitte Pegourie, Etienne Paubelle, Marguerite Vignon, Matteo Pelosini, Philippe Casassus, Isabelle Lambrecht, Laure Vincent, Eileen M Boyle, Annette Juul Vangsted, Pascal Bourquard, Laurent Mosser, Margaret Macro, Gerald Marit, Daniele Campa, Brigitte Kolb, Bruno Royer, Jean Fontan, Ramón García-Sanz, Philippe Moreau, Serge Leyvraz, Malgorzata Krawczyk-Kulis, Krzysztof Jamroziak, Joaquin Martinez-Lopez, Bruno Anglaret, Steven M. Lipkin, Nicole Frenkiel, Ofure Obazee, Marek Dudziński, Pascale Cony-Makhoul, Hervé Naman, Andres Jerez
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Leukemia, Vol. 33, no. 9, p. 2324-2330 (2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, ⟨10.1038/s41375-019-0452-6⟩
Leukemia, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Leukemia, vol. 33, no. 9, pp. 2324-2330
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Leukemia, Vol. 33, no. 9, p. 2324-2330 (2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, ⟨10.1038/s41375-019-0452-6⟩
Leukemia, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Leukemia, vol. 33, no. 9, pp. 2324-2330
French National Cancer Institute (INCA) and the Fondation Francaise pour la Recherche contre le Myelome et les Gammapathies (FFMRG), the Intergroupe Francophone du Myelome (IFM), NCI R01 NCI CA167824 and a generous donation from Matthew Bell. This wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a993d139f05bf9ec8d952d606cf7f6c
https://hal.univ-brest.fr/hal-02190723
https://hal.univ-brest.fr/hal-02190723
Autor:
Eric Jourdan, Carla Araujo, Eric Voog, Jean-Richard Eveillard, Murielle Roussel, Carine Chaleteix, Philippe Moreau, Claire Mathiot, Jean-Claude Eisenmann, Mohamad Mohty, Michel Attal, Karim Belhadj, Bruno Royer, Arnaud Jaccard, Gerald Marit, Aurore Perrot, Martine Escoffre-Barbe, Frédérique Kuhnowski, Lofti Benboubker, Ingrid Lafon, Marc Wetterwald, Pascal Lenain, Laurent Garderet, Anne-Marie Stoppa, Benoit Berge, Thierry Facon, Cyrille Hulin, Xavier Leleu, Brigitte Pegourie, Olivier Allangba, Mourad Tiab, Sabine Brechignac, Margaret Macro, Frédérique Orsini-Piocelle, Herve Avet Loiseau, Sylvie Glaisner, Lionel Karlin
Publikováno v:
Blood. 132(24)
It is important to have an effective therapy for patients with multiple myeloma (MM) at first relapse, particularly if an autologous stem cell transplant (ASCT) is considered at this stage. This multicenter, phase 2 trial evaluated the efficacy and s
Autor:
Philip L. McCarthy, Sarah A. Holstein, Maria Teresa Petrucci, Paul G. Richardson, Cyrille Hulin, Patrizia Tosi, Sara Bringhen, Pellegrino Musto, Kenneth C. Anderson, Denis Caillot, Francesca Gay, Philippe Moreau, Gerald Marit, Sin-Ho Jung, Zhinuan Yu, Benjamin Winograd, Robert D. Knight, Antonio Palumbo, Michel Attal
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (29), pp.3279-3289. ⟨10.1200/JCO.2017.72.6679⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (29), pp.3279-3289. ⟨10.1200/JCO.2017.72.6679⟩
Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c90cd491ac014a1bbef57b2f6073ac
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01697539
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01697539
Autor:
Thierry Facon, Supratik Basu, Olivier Decaux, Shen Zx, Troy H. Guthrie, Gerald Marit, Alessandro Corso, Nizar J. Bahlis, T de Revel, Annette Ervin-Haynes, Miquel Granell, Pierre Desjardins, Shang-Yi Huang, Jennifer Marek, Stoppa Am, Hareth Nahi, Guang Chen, Hilde Demuynck, Lars-Olof Mügge
Publikováno v:
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia
The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66267dcdbfc355f9d6234c1422b1ebcf
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6043
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6043
Autor:
Mathieu Puyade, Karim Belhadj, Brigitte Kolb, Carla Araujo, Arnaud Jaccard, Michel Attal, Odile Luycx, Thomas Dejoie, Bruno Royer, Laurent Garderet, Sylvie Glaisner, Pascal Lenain, Denis Caillot, Anne-Marie Stoppa, Karim Laribi, Hélène Caillon, Jean-Claude Eisenmann, Hervé Avet-Loiseau, Lucie Planche, Pascal Godmer, Jean-Paul Fermand, Philippe Rodon, Murielle Roussel, Marc Wetterwald, Jean-Valère Malfuson, Gerald Marit, Martine Escoffre, Laetitia Biron, Philippe Moreau, Mamoun Dib, Jean Fontan, Thierry Facon, Driss Chaoui, Brigitte Pegourie, Carine Chaleteix, Borhane Slama, Cyrille Hulin, Mourad Tiab, Sabine Brechignac, Margaret Macro, Olivier Allangba, Véronique Dorvaux
Publikováno v:
Blood. 127(21)
The Intergroupe Francophone du Myelome conducted a randomized trial to compare bortezomib-thalidomide-dexamethasone (VTD) with bortezomib-cyclophosphamide-dexamethasone (VCD) as induction before high-dose therapy and autologous stem cell transplantat